Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2023-06-22 00:00:00 ET · period of report 2023-06-21 · accession 0001104659-23-073568 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-22 | 2023-06-21 | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $17.88 | +500 | 3.23M | +0.0% | +$8,940 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-21 | P | A | 500 | $17.88 | 3,230,029 | D | — | — | (F1) Includes 426,759 shares of restricted stock. |